Posted in M&A / Deals Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis April 7, 2026 BioSpace The acquisition of Tubulis GmbH–Gilead Sciences’ latest of the year after buying Arcells and Ouro Medicines–brings into the fold a novel ovarian cancer candidate that has demonstrated promising mid-st M&A / DealsRead full story